Terms: = Uterine cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Diagnosis
6 results:
1. Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis.
Li C; Liu D; Yang S; Hua K
Front Immunol; 2022; 13():966291. PubMed ID: 36569924
[TBL] [Abstract] [Full Text] [Related]
2. An approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma.
Garcia-Chagollan M; Jave-Suarez LF; Haramati J; Bueno-Topete MR; Aguilar-Lemarroy A; Estrada-Chavez C; Bastidas-Ramirez BE; Pereira-Suarez AL; Del Toro-Arreola S
J Biomed Sci; 2015 Oct; 22():91. PubMed ID: 26486970
[TBL] [Abstract] [Full Text] [Related]
3. Cytokine serum levels in patients with cervical intraepithelial neoplasia grade II-III treated with intralesional interferon-α 2b.
Misson DR; Abdalla DR; Borges AM; Shimba DS; Adad SJ; Michelin MA; Murta EF
Tumori; 2011; 97(5):578-84. PubMed ID: 22158487
[TBL] [Abstract] [Full Text] [Related]
4. [Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (il-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report].
Pardo-Govea T; Callejas D; Núñez-Troconis J; Araujo M; Costa L; Pons H; Delgado M; Monsalve F
Invest Clin; 2005 Mar; 46(1):5-13. PubMed ID: 15782532
[TBL] [Abstract] [Full Text] [Related]
5. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors.
Punnonen R; Teisala K; Kuoppala T; Bennett B; Punnonen J
Cancer; 1998 Aug; 83(4):788-96. PubMed ID: 9708947
[TBL] [Abstract] [Full Text] [Related]
6. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract] [Full Text] [Related]
